Drawing for NASHNEXT

USPTO serial 99928816

NASHNEXT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with NASHNEXT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald M. Kachmarik

Ronald M. Kachmarik Cooper Legal Group, LLC1388 Ridge Road, Unit 1Hinckley, OH 44233United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software platforms for for purchasing medical diagnostic tests, accessing laboratory test results, managing personal health information, communicating healthcare-related information between healthcare professionals and patients and supporting physician-directed identification of patients at risk; Downloadable clinical decision support software; Downloadable software for risk assessment and patient stratificationACTIVE—
044Providing medical information, consultancy and advisory services; Medical evaluation services for identifying patients at risk for metabolic disorders, liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Medical screening services for identifying patients at risk of MASH and liver fibrosis; Patient risk stratification services; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical information and medical consultancy and advisory services in the nature of clinical interpretation of biomarkers and assessment of the risk of liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concernsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2026NWAPNEW APPLICATION ENTERED—
Jul 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance